Therapeutic indications

Apomorphine is indicated for:

Treatment of motor fluctuations ("on-off" phenomena) in patients with Parkinson's disease

Irrespective of gender only Adults (18 years old or older)

Apomorphine is indicated for the treatment of motor fluctuations (‘on-off’ phenomena) in patients with Parkinson’s disease which are not sufficiently controlled by oral anti-Parkinson medication.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Subcutaneous - Incremental dosing schedules according to the patient's response within the range of 3-100 mg


Active ingredient Apomorphine is contraindicated in the following cases:

Levodopa, severe dyskinesia or dystonia

Apomorphine HCl treatment must not be administered to patients who have an ‘on’ response to levodopa which is marred by severe dyskinesia or dystonia.

Respiratory depression, dementia, psychotic diseases, hepatic insufficiency